Madrid, Spain

Jose-Miguel Coteron

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Wellcome Inc.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jose-Miguel Coteron. Retrieved from https://idiyas.com/inventor/jose-miguel-coteron

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jose-Miguel Coteron

Introduction

Jose-Miguel Coteron is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of chemistry, particularly with his work on morpholino ethers. His innovative approach has led to the development of a patent that showcases his expertise and creativity.

Latest Patents

Jose-Miguel Coteron holds a patent for morpholino ethers. This invention reflects his commitment to advancing chemical research and applications. The patent is a testament to his skills and knowledge in the field.

Career Highlights

Coteron is currently associated with Glaxo Wellcome Inc., a prominent company in the pharmaceutical industry. His role there allows him to collaborate with other talented professionals and contribute to groundbreaking research and development.

Collaborations

Some of his coworkers include Jose M Bueno and Jesus Chicharro Gonzalo. Their collective efforts in the workplace foster an environment of innovation and creativity.

Conclusion

Jose-Miguel Coteron is a distinguished inventor whose work on morpholino ethers has made a significant impact in the field of chemistry. His contributions continue to inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…